Should Low-intensity Extracorporeal Shockwave Therapy Be the First-line Erectile Dysfunction Treatment for Nonresponders to Phosphodiesterase Type 5 Inhibition?

Abstract

Some trials have shown an overall benefit of low-intensity extracorporeal shockwave therapy (LI-ESWT) for erectile dysfunction, while others have been unable to find differences between LI-ESWT and sham treatment. In the absence of definitive evidence, patients should only be offered LI-ESWT in an investigational setting or on an off-label basis with a thorough understanding of the risks and benefits.

• Authors: Premal Patel, Mikkel Fode, Tom Lue, Ranjith Ramasamy
• Journal: European urology focus (Eur Urol Focus) Vol. 5 Issue 4 Pg. 526-528 (Jul 2019) ISSN: 2405-4569 [Electronic] Netherlands
• PMID: 30777724 (Publication Type: Journal Article)
• Copyright: Copyright © 2019. Published by Elsevier B.V.

Chemical References

• Phosphodiesterase 5 Inhibitors

Topics

• Erectile Dysfunction (drug therapy, therapy)
• Extracorporeal Shockwave Therapy (methods)
• Humans
• Male
• Phosphodiesterase 5 Inhibitors (therapeutic use)
• Practice Guidelines as Topic
• Treatment Failure